RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Items 401–500 of 1,009
Targeting TNF-α receptors for neurotherapeutics
Chadwick, W., Magnus, T., Martin, B., Keselman, A., Mattson, M. P., & Maudsley, S. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.005 · Cited by 78
Frequent Inactivation of RAMP2, EFEMP1 and Dutt1 in Lung Cancer by Promoter Hypermethylation
Yue, W., Đačić, S., Sun, Q., Landreneau, R. J., Guo, M., Zhou, W., Siegfried, J. M., Yu, J., & Zhang, L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0015 · Cited by 83
Kono, T., Koseki, T., Chiba, S., 海老澤, 良., Chisato, N., Iwamoto, J., & Kasai, S. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.02.057 · Cited by 83
The cardioprotection of calcitonin gene-related peptide-mediated preconditioning
Li, Y., & Peng, J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01538-8 · Cited by 83
Kubiak, T. M., Larsen, M. J., Nulf, S. C., Zantello, M. R., Burton, K. J., Bowman, J. W., Modric, T., & Lowery, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304861200 · Cited by 83
Extracellular Ca2+-sensing receptor is a promiscuous divalent cation sensor that responds to lead
Handlogten, M. E., Shiraishi, N., Awata, H., Huang, C., & Miller, R. T. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.6.f1083 · Cited by 83
Inherited ACTH insensitivity illuminates the mechanisms of ACTH action
Clark, A. J. L., Metherell, L. A., Cheetham, M. E., & Huebner, A. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.10.006 · Cited by 82
Fawzi, A. B., Macdonald, D., Benbow, L. L., Smith-Torhan, A., Zhang, H., Weig, B. C., Ho, G., Tulshian, D., Linder, M. E., & Graziano, M. P. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12353-x · Cited by 82
“Other regulatory proteins of GPCR function include arrestins (Lefkowitz, 1998), GPCR kinase (Lefkowitz, 1998), and receptor activity-modifying proteins (McLatchie et al., 1998).”
BackgroundYan, D., Liu, X., & Guo, S.-W. (2019) · Scientific Reports · doi:10.1038/s41598-019-39170-w · Cited by 82
RAMPs: 5 years on, where to now?
Morfis, M. M., Christopoulos, A., & Sexton, P. M. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.001 · Cited by 82
Trafficking prerogatives of olfactory receptors
McClintock, T. S., & Sammeta, N. (2003) · Neuroreport · doi:10.1097/00001756-200308260-00001 · Cited by 82
The receptor activity modifying protein family of G protein coupled receptor accessory proteins
Udawela, M., Hay, D. L., & Sexton, P. M. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2003.12.019 · Cited by 82
Decreased Gene Expression of Adrenomedullin Receptor in Mouse Lungs during Sepsis
Ono, Y., Okano, I., Kojima, M., Okada, K., & Kangawa, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2606 · Cited by 87
Cancer‐Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin
Wang, Z., Yang, Q., Tan, Y., Tang, Y., Ye, J., Yuan, B., & Yu, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.613534 · Cited by 81
Chang, J. R., Guo, J. F., Wang, Y., Hou, Y., Lu, W., Zhang, J. S., Yu, Y. R., Xu, M. J., Liu, X., Wang, X. J., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.029 · Cited by 86
CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured
Walker, C. S., Raddant, A. C., Woolley, M. J., Russo, A. F., & Hay, D. L. (2017) · Cephalalgia · doi:10.1177/0333102417691762 · Cited by 86
“Experiments with amylin at the CGRP receptor were not performed because amylin is a very weak agonist at this receptor (6,29).”
Husmann, K., Sexton, P. M., Fischer, J. A., & Born, W. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00212-4 · Cited by 83
Calcitonin and calcitonin receptor‐like receptors: common themes with family B GPCRs?
Barwell, J., Gingell, J. J., Watkins, H. A., Archbold, J. K., Poyner, D. R., & Hay, D. L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01525.x · Cited by 80
“of the membrane protein family called the receptor activitymodifying proteins (RAMPs), which consists of RAMP1, 2 and 3 in humans (McLatchie et al., 1998).”
BackgroundThe PACAP pathway is independent of CGRP in mouse models of migraine: possible new drug target?
Ernstsen, C., Christensen, S. L., Rasmussen, R. H., Nielsen, B. S., Jansen‐Olesen, I., Olesen, J., & Kristensen, D. M. (2022) · Brain · doi:10.1093/brain/awac040 · Cited by 82
SEXTON, P. M., MORFIS, M., TILAKARATNE, N., HAY, D. L., UDAWELA, M., CHRISTOPOULOS, G., & CHRISTOPOULOS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1317.076 · Cited by 80
Robert, J., Clauser, É., Petit, P. X., & Ventura, M. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410655200 · Cited by 83
Adrenomedullin and tumour microenvironment
Larráyoz, I. M., Martínez-Herrero, S., García-Sanmartín, J., Ochoa‐Callejero, L., & Martínez, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0339-2 · Cited by 86
“The CLR molecules transported by RAMP2 and RAMP3 are core-glycosilated and function as AM receptors (AMR); CLR/RAMP2 is known as AMR1, whereas CLR/RAMP3 is dubbed AMR2 [5,15].”
BackgroundIslet amyloid polypeptide: Another key molecule in Alzheimer’s pathogenesis?
Zhang, Y., & Song, W. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.001 · Cited by 83
“In addition, this metabolic effect of IAPP is enhanced in the mice with the overexpression of RAMP1, which is a component of the IAPP receptor complex (Fernandes-Santos et al., 2013; Tilakaratne et al., 2000; Zhang et al., 2011).”
BackgroundInfluentialMolecular Signature for Receptor Engagement in the Metabolic Peptide Hormone Amylin
Bower, R. L., Yule, L., Rees, T. A., Deganutti, G., Hendrikse, E. R., Harris, P. W. R., Kowalczyk, R., Ridgway, Z., Wong, A. G., Swierkula, K., et al. (2018) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00002 · Cited by 80
Endozepines and their receptors: Structure, functions and pathophysiological significance
Tonon, M.-C., Vaudry, H., Chuquet, J., Guillebaud, F., Fan, J., Masmoudi-Kouki, O., Vaudry, D., Lanfray, D., Morin, F., Prevot, V., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.008 · Cited by 71
Zudaire, E., Martínez, A., Garayoa, M., Pío, R., Kaur, G., Woolhiser, M. R., Metcalfe, D. D., Hook, W. A., Siraganian, R. P., Guise, T. A., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050291 · Cited by 84
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Lukács, M., Tajti, J., Fülöp, F., Toldi, J., Edvinsson, L. I., & Vécsei, L. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170712163437 · Cited by 83
Targeting receptor complexes: a new dimension in drug discovery
Ishoey, M., Clemmensen, L. S., Bredt, D. S., Bettler, B., & Strømgaard, K. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0086-4 · Cited by 79
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
Mathiesen, D. S., Lund, A., Vilsbøll, T., Knop, F. K., & Bagger, J. I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.617400 · Cited by 86
“There are several isotypes of the amylin receptor (37) which all are G proteincoupled receptors consisting of two units; a core unit constituted by the calcitonin receptor (7-transmembrane receptor) and one of three receptor activity-modifying proteins (RAMP1-3) (37).”
BackgroundTopology-function conservation in protein–protein interaction networks
Davis, D., Yaveroğlu, Ö. N., Malod-Dognin, N., Stojmirovic, A., & Pržulj, N. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv026 · Cited by 83
“For example, when the human proteins are ranked based on the similarity of their wiring patterns to the topological profile identified for cellular localization, the two highest ranking proteins, PLXNA2 and RAMP3, are transmembrane proteins (McLatchie et al., 1998; Pasterkamp, 2012).”
Moreno, M. J. L., Abounader, R., Hébert, E., Doods, H. N., & Hamel, É. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00008-4 · Cited by 79
Li, J., Kaminski, N. E., & Wang, D. H. (2003) · Hypertension · doi:10.1161/01.hyp.0000051641.58674.f7 · Cited by 79
Konkar, A. A., Zhu, Z., & Granneman, J. G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39154-2 · Cited by 90
“, 1999), perhaps in a manner analogous to that described for calcitonin generelated peptide receptors and receptor activity modifying proteins (McLatchie et al., 1998).”
Tanaka, M., Koyama, T., Sakurai, T., Kamiyoshi, A., Ichikawa‐Shindo, Y., Kawate, H., Liu, T., Xian, X., Imai, A., Zhai, L., et al. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw166 · Cited by 80
Structural perspective of class B1 GPCR signaling
Cong, Z., Liang, Y.-L., Zhou, Q., Darbalaei, S., Zhao, F., Feng, W., Zhao, L., Xu, H. E., Yang, D., & Wang, M.-W. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.01.002 · Cited by 80
Cottrell, G. S., Padilla, B. E., Pikios, S., Roosterman, D., Steinhoff, M. S., Grady, E. F., & Bunnett, N. W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606338200 · Cited by 82
Lenhart, P. M., Broselid, S., Barrick, C. J., Leeb-Lundberg, L. M. F., & Caron, K. M. (2013) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0021 · Cited by 76
Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
Weston, C., Lu, J., Li, N., Barkan, K., Richards, G. O., Roberts, D. J., Skerry, T. M., Poyner, D., Pardamwar, M., Reynolds, C. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.624601 · Cited by 77
“The three RAMPs (RAMP1, RAMP2, and RAMP3) were first identified as being essential components of the receptors for calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) (11).”
BackgroundMethodResultInfluentialCalcitonin and Amylin Receptor Peptide Interaction Mechanisms
Lee, S. M., Hay, D. L., & Pioszak, A. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713628 · Cited by 79
“CLR RAMP2 and CLR RAMP3 are the AM1 and AM2 receptors, respectively, at which AM is more potent than CGRP (1).”
BackgroundMultiplexed analysis of the secretin-like GPCR-RAMP interactome
Lorenzen, E., Dodig‐Crnković, T., Kotliar, I. B., Pin, E., Ceraudo, E., VAUGHAN, R. D., Uhlén, M., Huber, T., Schwenk, J. M., & Sakmar, T. P. (2019) · Science Advances · doi:10.1126/sciadv.aaw2778 · Cited by 78
Melanocortin receptors and their accessory proteins
Cooray, S. N., & Clark, A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.07.015 · Cited by 94
“The receptor activity modifying proteins (RAMP 1, 2 and 3) are associated with the trafficking of the calcitonin like receptor (CLR) and thought to be linked throughout the life cycle of the CLR (McLatchie et al, 1998; Fraser et al, 1999; Kuwasako et al, 2000).”
BackgroundEdvinsson, L. I. (2001) · CNS Drugs · doi:10.2165/00023210-200115100-00001 · Cited by 78
“McLatchie and co-workers[32] demonstrated that functional CGRP1 and adrenomedullin receptors are both derived from CRLR, and that the phenotype is determined by co-expression with a particular receptor activity modifying protein, RAMP.”
BackgroundCalcitonin Gene-Related Peptide Regulates Expression of Neurokinin1Receptors by Rat Spinal Neurons
Seybold, V. S., McCarson, K. E., Mermelstein, P. G., Groth, R. D., & Abrahams, L. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01816.2003 · Cited by 78
“**p Ͻ 0.001 compared with control within the same type of culture (two-way ANOVA with Tukey's multiplecomparisons test). which the receptor couples (McLatchie et al., 1998; Chakravarty et al., 2000; Evans et al., 2000).”
BackgroundInfluentialBomberger, J. M., Spielman, W. S., Hall, C. S., Weinman, E. J., & Parameswaran, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501751200 · Cited by 75
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
“Similarly, when CRLR dimerizes with RAMP2 and RAMP3, receptor having affinity with an adrenomedullin receptor is produced [68].”
BackgroundLee, H. Y., Bowen, C. H., Popescu, G. V., Kang, H.-G., Kato, N., Ma, S., Dinesh‐Kumar, S. P., Snyder, M. P., & Popescu, S. C. (2011) · The Plant Cell · doi:10.1105/tpc.111.089656 · Cited by 88
“…that animal receptor trafficking is controlledbyERmembrane–localized receptor accessoryproteins that bind to their cytoplasmic tails and recruit transport complexes (McLatchie et al., 1998; Petaja-Repo et al., 2000; Bermak et al., 2001; Dupré and Hébert, 2006; Cooray et al., 2009; Dı́az, 2010).”
BackgroundTruncation Releases Olfactory Receptors from the Endoplasmic Reticulum of Heterologous Cells
Gimelbrant, A. A., Stoss, T. D., Landers, T. M., & McClintock, T. S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722301.x · Cited by 83
Induction of a Myocardial Adrenomedullin Signaling System During Ischemic Heart Failure in Rats
Øie, E., Vinge, L. E., Yndestad, A., Sandberg, C. J., Grøgaard, H. K., & Attramadal, H. (2000) · Circulation · doi:10.1161/01.cir.101.4.415 · Cited by 80
Cerebral Endothelial Cells are a Major Source of Adrenomedullin
Kis, B., Kaiya, H., Nishi, R., Deli, M. A., Ábrahám, C. S., Yanagita, T., Isse, T., Gotoh, S., Kobayashi, H., Wada, A., et al. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00778.x · Cited by 76
Transmembrane signal transduction by peptide hormones via family B G protein-coupled receptors
Culhane, K. J., Liu, Y., Cai, Y., & Yan, E. C. Y. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00264 · Cited by 72
Choksi, T., Hay, D. L., Legon, S., Poyner, D. R., Hagner, S., Bloom, S. R., & Smith, D. M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704761 · Cited by 73
“Interestingly, the speci®city of CRLR for these peptides is conferred by a novel family of single transmembrane proteins, termed receptor-activity modifying proteins (RAMPs, McLatchie et al., 1998).”
BackgroundMethodResultInfluentialThe role of the CGRP-receptor component protein (RCP) in adrenomedullin receptor signal transduction
Prado, M. A., Evans-Bain, B., Oliver, K. R., & Dickerson, I. M. (2001) · Peptides · doi:10.1016/s0196-9781(01)00517-4 · Cited by 82
Edelman, S. V., & Weyer, C. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/15209150260007390 · Cited by 75
In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain
Paxinos, G., Chai, S. Y., Christopoulos, G., Huang, X., Toga, A. W., Wang, H.-Q., & Sexton, P. M. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.03.005 · Cited by 81
Xie, Z., Bhushan, R. G., Daniels, D. J., & Portoghese, P. S. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012070 · Cited by 85
“However, such a model has been challenged by a growing number of studies that have implicated the existence of GPCR dimers/oligomers in cultured cells and in the native state (McLachie et al., 1998; Zawarynski et al., 1998; Zeng and Wess, 1999; George et al., 2000; Gomes et al., 2000; Salahpour et al., 2000; Dean et a…”
BackgroundGLP‐1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
Roth, J. D., Erickson, M. R., Chen, S., & Parkes, D. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01537.x · Cited by 74
Hay, D. L., Walker, C. S., & Poyner, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0244 · Cited by 80
Calcitonin Gene-Related Peptide Receptor Antagonists: New Therapeutic Agents for Migraine
Bell, I. M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500364u · Cited by 79
In-depth characterization of CGRP receptors in human intracranial arteries
Jansen‐Olesen, I., Jørgensen, L., Engel, U., & Edvinsson, L. I. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.09.021 · Cited by 74
A role for adrenomedullin as a pain-related peptide in the rat
Ma, W., Chabot, J., & Quirion, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602488103 · Cited by 74
Muff, R., Leuthäuser, K., Bühlmann, N., Foord, S. M., Fischer, J. A., & Born, W. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01587-7 · Cited by 73
Self-citationEdvinsson, L. I., Sams, A. G., Jansen‐Olesen, I., Tajti, J., Kane, S. A., Rutledge, R. Z., Koblan, K. S., Hill, R. G., & Longmore, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00934-1 · Cited by 74
Cooray, S. N., Almiro Do Vale, I., Leung, K.-Y., Webb, T. R., Chapple, J. P., Egertová, M., Cheetham, M. E., Elphick, M. R., & Clark, A. J. L. (2008) · Endocrinology · doi:10.1210/en.2007-1463 · Cited by 73
“Dopamine receptor interacting protein (DRiP78) is required for the trafficking of the D1 dopamine receptor (17), and the small single-transmembrane domain proteins receptor activity modifying proteins (RAMPs) are required for trafficking and ligand specificity of the calcitonin receptor and the calcitonin-like recepto…”
BackgroundNew Insights into the Structure and Function of Class B1 GPCRs
Cary, B. P., Zhang, X., Cao, J., Johnson, R. M., Piper, S. J., Gerrard, E. J., Wootten, D. L., & Sexton, P. M. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac033 · Cited by 77
Bench-to-bedside pharmacology of adrenomedullin
Kato, J., & Kitamura, K. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.061 · Cited by 79
“2) (McLatchie et al., 1998).”
BackgroundInfluentialAdrenomedullin stabilizes the lymphatic endothelial barrier in vitro and in vivo
Dunworth, W. P., Fritz-Six, K. L., & Caron, K. M. (2008) · Peptides · doi:10.1016/j.peptides.2008.09.009 · Cited by 70
“AM transduces its signal through a G-protein coupled receptor, calcitonin receptor-like receptor (CLR) when the receptor is associated with receptor activity modifying protein 2 (RAMP2) [26].”
BackgroundInfluentialModulating receptor function through RAMPs: can they represent drug targets in themselves?
Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.009 · Cited by 81
Qi, T., Christopoulos, G., Bailey, R. J., Christopoulos, A., Sexton, P. M., & Hay, D. L. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.047142 · Cited by 73
“We used mycRAMP1 because its behavior has been shown to be equivalent to that of WT RAMP1 (McLatchie et al., 1998).”
BackgroundMethodInfluentialMiller, S., Liu, H., Warfvinge, K., Shi, L., Dovlatyan, M., Xu, C., & Edvinsson, L. I. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.04.046 · Cited by 73
van der Westhuizen, E. T., Tilakaratne, N., Fraser, N. J., Christopoulos, G., Foord, S. M., & Sexton, P. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1943 · Cited by 74
Self-citationRubin, D. A., Hellman, P., Zon, L. I., Lobb, C. J., Bergwitz, C., & Jüppner, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23035 · Cited by 73
Dakhama, A., Kanehiro, A., Mäkelä, M. J., Loader, J. E., Larsen, G. L., & Gelfand, E. W. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.8.2109058 · Cited by 77
Mediators of Amylin Action in Metabolic Control
Boyle, C. N., Zheng, Y., & Lutz, T. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082207 · Cited by 67
“Further, we are not aware of studies characterizing AMY receptors with all their receptor components in the periphery since the first description of RAMPs in 1998 [42].”
BackgroundGPCRs in Intracellular Compartments: New Targets for Drug Discovery
Fasciani, I., Carli, M., Petragnano, F., Colaianni, F., Aloisi, G., Maggio, R., Scarselli, M., & Rossi, M. (2022) · Biomolecules · doi:10.3390/biom12101343 · Cited by 78
“Receptor activity-modifying proteins (RAMPs) are a family of three single pass membrane proteins that were initially discovered as regulators of the calcitonin receptor-like receptor (CLR) function and plasma membrane expression [72].”
BackgroundShared and separate functions of the RAMP-based adrenomedullin receptors
Kuwasako, K., Kitamura, K., Nagata, S., Hikosaka, T., Takei, Y., & Kato, J. (2011) · Peptides · doi:10.1016/j.peptides.2011.05.022 · Cited by 76
Fernández, A. P., Serrano, J., Tessarollo, L., Cuttitta, F., & Martínez, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803174105 · Cited by 69
“The receptor system for AM consists of a heterodimer composed of calcitonin receptor-like receptor (CLR) and receptor activity modifying protein (RAMP) type 2 or 3 (2).”
BackgroundSchaeffer, C., Vandroux, D., Thomassin, L., Athias, P., Rochette, L., & Connat, J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.09.005 · Cited by 77
“[34] demonstrated that a family of proteins called receptoractivity-modifying proteins (RAMPs) was able to combine calcitonin-receptor-like receptor (CRLR) and to traffic it to the plasma membrane.”
BackgroundDong, C., & Wu, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605734200 · Cited by 73
Adrenomedullin is a novel adipokine: adrenomedullin in adipocytes and adipose tissues
Li, Y., Jiang, C., Wang, X., Zhang, Y., Shibahara, S., & Takahashi, K. (2007) · Peptides · doi:10.1016/j.peptides.2007.03.005 · Cited by 71
GABAB receptor heterodimer-component localisation in human brain
Billinton, A., Ige, A. O., Wise, A., White, J. H. M., Disney, G. H., Marshall, F. H., Waldvogel, H. J., Faull, R. L. M., & Emson, P. C. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00047-4 · Cited by 71
Self-citationWebb, T. R., Chan, L., Cooray, S. N., Cheetham, M. E., Chapple, J. P., & Clark, A. J. L. (2009) · Endocrinology · doi:10.1210/en.2008-0941 · Cited by 71
Sebag, J. A., & Hinkle, P. M. (2010) · Science Signaling · doi:10.1126/scisignal.2000593 · Cited by 72
Liberini, C. G., Boyle, C. N., Cifani, C., Venniro, M., Hope, B. T., & Lutz, T. A. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13163 · Cited by 66
Villa, I., Mrak, E., Rubinacci, A., Ravasi, F., & Guidobono, F. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00354.2005 · Cited by 68
“The coexpression of CLR and RAMP2 gives rise to a receptor with greater affinity for adrenomedullin (23, 29), a member of the calcitonin peptide family, which, like CGRP, has mitogenic effects on osteoblasts (9).”
BackgroundRegulation of apoptosis by vasoactive peptides
Filippatos, G. S., Gangopadhyay, N. N., Lalude, O. O., Parameswaran, N., Said, S. I., Spielman, W. S., & Uhal, B. D. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.4.l749 · Cited by 86
“The interaction and affinity of these two ligands to this receptor are regulated by the expression of accessory proteins called receptor activity-modifying proteins (RAMPs) ( 58 ).”
BackgroundMapp, P. I., McWilliams, D. F., Turley, M. J., Hargin, E., & Walsh, D. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01848.x · Cited by 70
“RAMP1 confers specificity for CGRP (Hay et al., 2004), whilst RAMPs 2 and 3 confer specificity for adrenomedullin (McLatchie et al., 1998; see Walker et al. (2010: Recober and Russo (2009).”
BackgroundFamilial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action
Chan, L. F., Clark, A. J. L., & Metherell, L. A. (2008) · Hormone Research in Paediatrics · doi:10.1159/000111810 · Cited by 71
“but not all families segregate to chromosome 8 suggesting the involvement of additional genes. Receptor Accessory Proteins The discovery of MRAP has provided a new mechanism of melanocortin receptor regulation which was previously unknown. Small single transmembrane proteins such as the RAMPs, RTPs and REEPs are a gro…”
BackgroundDuvernay, M. T., Dong, C., Zhang, X., Zhou, F., Nichols, C. D., & Wu, G. (2009) · Molecular Pharmacology · doi:10.1124/mol.108.051623 · Cited by 71
“Consistent with this possibility, a number of accessory proteins directly interact with the GPCR C termini to modulate receptor export (Ferreira et al., 1996; McLatchie et al., 1998).”
BackgroundExpression and purification of recombinant G protein-coupled receptors: A review
Wiseman, D. N., Otchere, A., Patel, J. H., Uddin, R., Pollock, N. L., Routledge, S. J., Rothnie, A. J., Slack, C., Poyner, D. R., Bill, R. M., et al. (2019) · Protein Expression and Purification · doi:10.1016/j.pep.2019.105524 · Cited by 77
“These include poly-histidine [55,58], FLAG [56,133], HA [134], Strep-Tactin [135], Rho [136] and EF1 [137] tags among others.”
BackgroundCalcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity
Yallampalli, C., Chauhan, M., Thota, C. S., Kondapaka, S. B., & Wimalawansa, S. J. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00563-5 · Cited by 74
Cellular and sub-cellular localisation of GABAB1 and GABAB2 receptor proteins in the rat cerebellum
Ige, A. O., Bolam, J. P., Billinton, A., White, J. H. M., Marshall, F. H., & Emson, P. C. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00199-6 · Cited by 70
Chemokine receptor trafficking and viral replication
Pelchen‐Matthews, A., Signoret, N., Klasse, P. J., Fraile‐Ramos, A., & Marsh, M. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01281.x · Cited by 69
Fletcher, M. M., Keov, P., Truong, T. T., Mennen, G., Hick, C. A., Zhao, P., Furness, S. G. B., Kruse, T., Clausen, T. R., Wootten, D., et al. (2021) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000567 · Cited by 68
“Human RAMP1 and RAMP3 were a gift from Dr. Steve Foord (McLatchie et al., 1998).”
MethodTreatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system
Link, A., Kuris, A., & Edvinsson, L. I. (2008) · The Journal of Headache and Pain · doi:10.1007/s10194-008-0011-4 · Cited by 69
“Apart from contributing to the receptor specificity, RAMP1 is required for glycosylation and transport of CLR to the plasma membrane [48–50].”
BackgroundFunctional Rescue of β1‐Adrenoceptor Dimerization and Trafficking by Pharmacological Chaperones
Kobayashi, H., Ogawa, K., Yao, R., Lichtarge, O., & Bouvier, M. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00932.x · Cited by 68
Impairment of GABAB receptor dimer by endogenous 14‐3‐3ζ in chronic pain conditions
Laffray, S., Bouali‐Benazzouz, R., Papon, M.-A., Favereaux, A., Jiang, Y., Holm, T., Spriet, C., Desbarats, P., Fossat, P., Feuvre, Y. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.161 · Cited by 69
“To date, the regulation of GPCR oligomerization is known to depend on receptor targeting (McLatchie et al , 1998; Margeta-Mitrovic et al , 2000) or ligand binding (Rocheville et al , 2000).”
Neuronal Receptor Activity–Modifying Protein 1 Promotes Energy Expenditure in Mice
Zhang, Z., Liu, X., Morgan, D. A., Kuburas, A., Thedens, D. R., Russo, A. F., & Rahmouni, K. (2011) · Diabetes · doi:10.2337/db10-0692 · Cited by 70
“RAMP1 interacts with calcitonin-like receptor (CLR) to yield calcitonin gene-related peptide (CGRP) receptor binding specificity (1,5).”
BackgroundResultInfluentialCurtis Hewitt, S., Collins, J., Grissom, S., Deroo, B., & Korach, K. S. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0142 · Cited by 69
Isumi, Y., Kubo, A., Katafuchi, T., Kangawa, K., & Minamino, N. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01615-4 · Cited by 69
Wang, C., Dobrzynski, E., Chao, J., & Chao, L. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.6.f964 · Cited by 70
“Recent studies have shown that both AM and CGRP signal through a common receptor with seven transmembrane domains, the calcitonin receptor-like receptor ( 17 ).”
Background
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.